To retain target biotech company employees—arguably as vital to success as the pipeline being acquired—biopharmas need talent strategies that focus on three key areas.
Education
- PhD, finance, WHU Otto Beisheim School of Management
- MBA, WHU Otto Beisheim School of Management
André Kronimus is Boston Consulting Group’s global topic leader for corporate finance and strategy in health care (biopharma and medtech) and chemicals. He is a member of the firm’s global Health Care and Corporate Finance and Strategy practice leadership teams and coleads BCG's Corporate Finance Task Force in Europe. He is also a core member of the Industrial Goods practice, with a particular focus on the chemical and agrochemical industry.
Since joining BCG in 2003, André has worked extensively in mergers and acquisitions in the US, Europe, and Asia, on both the buy and sell sides.
He has also worked with numerous clients on a wide range of corporate development topics, including corporate and portfolio strategy, growth strategy, and industry landscaping, plus finance organization and processes, primarily in the biopharma, medtech, and chemical sectors. André frequently advises private-equity funds on due diligence and portfolios.
Before joining BCG, André worked as a research and teaching assistant in finance at the WHU Otto Beisheim School of Management.
